6H-Dibenzo[b,d]pyran-9-methanol, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-propyl-, (6aR,10aR)-

(?)-11-hydroxy-Δ⁸-Tetrahydrocannabivarin (exempt preparation) is an analytical reference standard categorized as a synthetic cannabinoid.¹ (?)-11-hydroxy-Δ⁸-Tetrahydrocannabivarin is a metabolite of Δ⁸-tetrahydrocannabivarin . (?)-11-hydroxy-Δ⁸-Tetrahydrocannabivarin is regulated as a Schedule I compound in the United States. (?)-11-hydroxy-Δ⁸-Tetrahydrocannabivarin (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

1. Bátkai, S., Mukhopadhyay, P., Horváth, B., et al. Δ⁸-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB₂ receptors Br. J. Pharmacol. 165(8),2450-2461(2012).